In GBM, miR-223-3p functions as a tumor-suppressor miRNA; its overexpression enhances radio-/chemosensitivity in cell culture models as miR-223-3p targets ataxia telangiectasia mutated (ATM) [40]. Here, ATM is linked to glioblastoma.